Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
about
Genomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our EnvironmentUpdate on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsEvaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill ExperimentsEmergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children's hospital. Risk factors and clinical characteristicsTherapy of Infections due to Carbapenem-Resistant Gram-Negative PathogensRisk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species.Stenotrophomonas maltophilia endophthalmitis caused by surgical equipment contamination: an emerging nosocomial infection.Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control StudyMechanisms of antimicrobial resistance in Gram-negative bacilli.Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia.One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation.Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia.Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy.Stenotrophomonas maltophilia: An Emerging Pathogen in Paediatric Population.Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.Stenotrophomonas maltophilia ventilator-associated pneumonia. A retrospective matched case-control study.Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection.Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.Epidemiology and outcomes of Stenotrophomonas maltophilia and Burkholderia cepacia infections among trauma patients of India: a five year experience.Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
P2860
Q26742183-D829B558-8150-4A6D-82E3-91B16EBF6EB9Q26782924-9ED5F449-BEBE-4F18-BF27-51B743944239Q28550910-74210601-2D20-4268-B876-5634CA50F22AQ33735341-7A0B4811-DB4B-4DCA-BBC9-F284B7EEAC52Q34303970-C4268BAE-52B5-4705-B0C5-9CE1104B22A1Q34466373-CABCBC49-89FA-408D-A235-C82DEB4A5420Q35017760-B34EC5B9-F18D-457C-9F5F-45C7D5ADD4B0Q35018533-8FCA1B8A-6D09-4271-B154-7581B6D91760Q35711892-C458BAE0-1898-4106-94C4-8BEC51CA58E1Q35935319-968974F5-3556-40A3-9753-893D78F1FBF9Q36158458-EB6A4CBF-9BBF-4DCB-A78F-CB2B4D3599EBQ37094805-1A4FDE89-FDAF-4D0E-ACDA-846B9A9729E3Q37165015-F959BBD3-5B99-4B78-9667-AD5C428C05F0Q37366281-D4E9BAC1-78AA-487B-BED4-7B3C92F51005Q37663609-36A66FD2-E102-4E30-9CB8-2E92F5E996E9Q37681071-4C6439AE-0471-4955-B2DF-BB5F2892E3A2Q38247296-86C06686-ED70-4916-8BFE-4013DD2D00C5Q38875315-936ED5D0-17E0-407A-9052-BC9BF8C463DFQ40072110-A078EB09-ECF5-4F5B-A6FC-90BC0A45A722Q40665545-AFAF815B-0D73-4CA0-88AE-F3504F61A2F3Q40925635-715C4789-F2F0-424B-97C4-C7CBAF6A43CAQ41995146-E9865BBB-C573-4263-811F-83F7DCFB108FQ42381089-F82008D7-1B6E-42C5-ADDD-C97313C01BCEQ47126542-6A1DE64A-B10A-4CC0-BE5C-59A016606C10Q47594863-ED44DA39-BFA9-4F90-8EC2-282A40CCDD8B
P2860
Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Monotherapy with fluoroquinolo ...... omonas maltophilia infections.
@en
Monotherapy with fluoroquinolo ...... omonas maltophilia infections.
@nl
type
label
Monotherapy with fluoroquinolo ...... omonas maltophilia infections.
@en
Monotherapy with fluoroquinolo ...... omonas maltophilia infections.
@nl
prefLabel
Monotherapy with fluoroquinolo ...... omonas maltophilia infections.
@en
Monotherapy with fluoroquinolo ...... omonas maltophilia infections.
@nl
P2093
P2860
P356
P1476
Monotherapy with fluoroquinolo ...... omonas maltophilia infections.
@en
P2093
John Papadopoulos
Marco R Scipione
Yanina Dubrovskaya
Yu Lin Wang
P2860
P304
P356
10.1128/AAC.01324-13
P407
P577
2013-10-21T00:00:00Z